La votación fue aprobada 5-2 después del rechazo público por preocupaciones de privacidad.

Albion Financial Group UT adquirió una nueva participación en acciones de Axon Enterprise, Inc (NASDAQ:AXON - Free Report) en el tercer trimestre, según la compañía en su presentación más reciente del Formulario 13F ante la Comisión de Bolsa y Valores (SEC). La firma adquirió 5.654 acciones de la biotecnológica

Axon Enterprise (AXON) reached $403.02 at the closing of the latest trading day, reflecting a +2.64% change compared to its last close.

Cherokee County residents voiced concerns Tuesday about a proposed consolidated Cherokee Sheriff’s Office technology contract with Axon Enterprise Inc. for $37 million over 10 years.

Quadrant Capital Group LLC lifted its holdings in Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 1,844.7% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 77,126 shares of the biotechnology company

Sowell Financial Services LLC lifted its holdings in Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 1,652.0% in the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 142,492 shares of the biotechnology company

Robeco Institutional Asset Management B.V. lifted its holdings in Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 391,214.9% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 6,988,884 shares of the biot

Nisa Investment Advisors LLC lifted its holdings in shares of Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 15,688.2% during the third quarter, according to its most recent disclosure with the SEC. The fund owned 816,252 shares of the biotechnology company

Physician Wealth Advisors Inc. boosted its position in shares of Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 851.6% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,464 shares of the biotechnology

Diversify Advisory Services LLC lifted its holdings in shares of Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 61,418.0% during the third quarter, according to its most recent disclosure with the SEC. The fund owned 433,087 shares of the biotechnology company